The effects of selective A 1 receptor agonist on human spermatozoa were examined to verify physiological responses and to investigate the signal transduction pathway. N 6 -Cyclopentyladenosine on uncapacitated spermatozoa did not induce spontaneous acrosome reaction after 5 h capacitation, whereas the number of capacitated spermatozoa, assessed by lysophosphatidylcholine-induced acrosome reaction with Pisum sativum agglutinin staining, was significantly increased. N 6 -Cyclopentyladenosine was also added to capacitated human spermatozoa to find out whether the agonist could induce the acrosome reaction. Results, although statistically significant, could not be considered biologically significant. A 1 -Mediated capacitation was followed by the increase of tyrosine phosphorylation of a protein subset ranging between M r ‫؍‬ 200 000 and 30 000. Stimulation of A 1 receptor with the selective agonist elicited an agonist-induced inositol phospholipid hydrolysis leading to a transient rise of inositol triphosphate (IP 3 ). This increase was not induced by A 1 receptor antagonist and was blocked by phospholipase C inhibitor. Coimmunoprecipitation experiments showed that the A 1 receptor is coupled to G␣ i2 subunit suggesting that the activation of phospholipase C is mediated by ␤␥ subunits. In conclusion, the A 1 adenosine receptor in human spermatozoa is coupled to G␣ i2 , signals via IP 3 , and affects the capacitative status of ejaculated spermatozoa. acrosome reaction, gamete biology, male reproductive tract, signal transduction, sperm capacitation
INTRODUCTION
The process of capacitation enables spermatozoa to interact with the zona pellucida and to undergo the acrosome reaction (AR), both crucial steps toward fertilization. Therefore to become fertilization competent, mammalian sperm must spend a period of time in either the female reproductive tract or in suitable in vitro environments.
Capacitation and AR are related to many effectors and signal transduction pathways, but the molecules and the molecular basis of these important events are still only partially known [1] [2] [3] [4] [5] .
Adenosine is able to elicit biphasic responses in mammalian spermatozoa: stimulatory in uncapacitated cells and inhibitory in capacitated cells [6] . Mammalian spermatozoa have adenosine receptors, either stimulatory (A 2 ) or inhibitory (A 1 ) [7] [8] [9] [10] [11] [12] .
Specific A 2 agonists affected capacitation, enhanced fer- tilizing ability, and increased the cAMP content of uncapacitated mouse spermatozoa [7] . The same agonist, used with human spermatozoa, confirmed the presence of A 2 adenosine receptors responsible for adenosine-mediated enhancement of sperm motility [8] , cAMP production, and protein phosphorylation [9] . Recent studies have provided evidence that responses to adenosine in uncapacitated mouse and boar spermatozoa involve stimulatory A 2A adenosine receptors, whereas responses in capacitated cells involve inhibitory A 1 adenosine receptors (A 1 AR) [13, 14] . We have solubilized, characterized, and localized the A 1 AR in mammalian spermatozoa [10] [11] [12] . We have also reported [15] that A 1 ARs are involved in calcium mobilization, which is essential for regulating sperm function [16] .
The present study was designed to investigate further A 1 ARs and their signaling pathways and to assess their role in the mechanisms by which the fertilizing potential of human spermatozoa is enhanced using the highly specific agonist N 6 -cyclopentyladenosine (CPA) [17] .
MATERIALS AND METHODS

Materials
Biotrak [ 3 H]inositol triphosphate (IP 3 ) assay system and protein A Sepharose CL4B were from Amersham Pharmacia Biotech (Rainham, UK). Polyvinylidene fluoride (PVDF) and silver stain plus kit were from Bio-Rad Laboratories (Hercules, CA). Rabbit anti-A 1 AR antibody PC21 was a gift from Prof. R. Franco (Barcelona, Spain) and elsewhere thoroughly characterized [18] . Rabbit anti-G␣ i2 subunit antibody was from Calbiochem Biosciences (La Jolla, CA). All other products were from Sigma Chemical Co. (St. Louis, MO).
Sperm Preparation
Human semen with normal sperm characteristics according to World Health Organization criteria (vol ഡ 2 ml, concentration Ն20 ϫ 10 6 cells/ml; motility Ն50%, normal morphology Ն15%) was collected by masturbation from healthy donors. After liquefaction at 37ЊC, motile spermatozoa were selected by centrifugation at 800 ϫ g for 10 min through a two-step Percoll density gradient (90% v/v and 40% v/v). The pellet was washed twice at 800 ϫ g for 10 min and suspended at a concentration of 10 ϫ 10 6 cell/ ml in 95 mM NaCl, 4.8 mM KCl, 1.7 mM CaCl 2 , 1.2 mM MgSO 4 , 25 mM NaHCO 3 , 5.6 mM fructose, 0.25 mM sodium pyruvate, 3.7 ml/L sodium lactate (60% syrup), 20 mM Hepes, 10 U/ml penicillin, 10 mg/ml streptomycin (BWW medium). In capacitation experiments, 0.3% BSA was added to BWW (BWW-BSA) [19] .
Cell viability was assessed with propidium iodide by fluorescent microscopy.
Assessment of Capacitation and AR
Sperm were assayed for capacitation by induction of AR with L-␣-lysophosphatidylcholine (LPC) at 100 g/ml. This concentration of LPC was previously shown to induce the AR in capacitated sperm while having no effects on uncapacitated sperm [20] . To induce the AR with LPC, 10 ϫ 10 6 sperm were incubated for 5 h in BWW-BSA at 37ЊC in 5% CO 2 , 95% humidified air. At the end of the incubation, LPC was added at 100 g/ml, and the sperm were incubated an additional 15 min. Prior to drying and staining, randomly selected slides containing ϳ10 5 cells were examined to verify sperm motility and viability. The percentage of sperm that were acrosome-reacted was determined on air-dried sperm smears with Pisum sativum agglutinin fluorescein isothiocyanate conjugated (PSA-FITC) [21] . At least 200 cells were scored with an Axioplan Zeiss epifluorescence microscope equipped with a 390-525-nm filter (Gottingen, Germany) according to the following patterns: 1) selective staining of the whole acrosome (unreacted cells); 2) no staining or limited to the equatorial segments (reacted cells).
In experiments performed to determine whether specific A 1 agonist had a capacitative effect on uncapacitated spermatozoa, the protocol was modified by substituting BSA with CPA. The capacitative status was assayed by induction of AR with LPC, and the capacitative effect of CPA was evaluated by comparing the AR rate promoted by LPC in the control (BWW-BSA) and in the described experimental conditions (BWW-CPA).
In experiments performed to determine whether a specific A 1 agonist can act as AR initiator, LPC was substituted by CPA. Sperm were capacitated in BWW-BSA as described. At the end of the incubation, CPA was added and additionally incubated for 15 min. Acrosome-reacted cells were evaluated by PSA-FITC staining. The ability of CPA to induce AR was expressed as the difference between the AR rate promoted by CPA and the spontaneous AR rate observed in the control (BWW-BSA).
The A 1 agonist and antagonist were always used in the presence of 0.2 U/ml adenosine deaminase (ADA) because of the role of A 1 AR as an ADA-binding protein [22] .
Inositol Triphosphate Determination
Determination of sperm IP 3 concentration was performed with the Biotrak [ 3 H]IP 3 assay system (Amersham Pharmacia Biotech, Rainham, U.K.) following the manufacturer's procedure. Spermatozoa, prepared as described, were suspended in BWW and aliquoted at 3 ϫ 10 4 cells/vial. Adenosine receptor agonist and antagonist plus ADA at 0.2 U/ml were added and trichloroacetic acid (TCA)-precipitation/diethyl ether extraction initiated at 40 sec. For each sample, IP 3 content of the spermatozoa at 0 time was evaluated (control value).
When the effects of other reagents were examined, the products were added at 37ЊC 15 min before the addition of the A 1 agonist.
Immunoprecipitation Procedure
Human sperm (700 ϫ 10 6 cells), washed in PBS at 800 ϫ g for 10 min at room temperature (RT), was suspended in cold 50 mM Tris-HCl, pH 7.4 containing 0.5% digitonin, 0.5% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), and protease inhibitor cocktail. After sonication (Virsonic 50; Virtis Co., Gardiner, NY) on ice with 15 bursts of 10 sec (10-sec intervals) and extraction for 60 min at 4ЊC, the supernatant was obtained by ultracentrifugation at 105 000 ϫ g (1 h at 4ЊC). The preparation was assayed with a Bio-Rad DC protein assay kit (Bio-Rad Laboratories, Richmond, CA) for protein quantitation. Aliquots of the detergent extracts (about 400 g protein) were incubated with the antibodies (PC21 and anti-G␣ i2 at 12 g/ml) previously coupled to protein A Sepharose CL4B by an overnight incubation at 4ЊC in constant rotation. Nonspecific immunoprecipitation was assessed by using the same amount of rabbit nonimmune IgG. The mixture was incubated for 3 h at 4ЊC with constant rotation. Immunoprecipitates were washed twice with 0.5% digitonin, 0.5% CHAPS in Tris-HCl 50 mM, NaCl 140 mM, NaN 3 0.025% (TSA buffer), twice with 0.1% digitonin, 0.1% CHAPS in TSA buffer, and once with TSA buffer alone. Pelleted samples were then dissolved in 60 l 2ϫ SDS-PAGE sample buffer, boiled for 3 min, and centrifuged at 12 000 ϫ g for 2 min. The supernatant was analyzed by SDS-PAGE at 15% [23] . After PAGE, the gels were stained with a silver staining kit (Bio-Rad).
Western Blot Procedure
Immunoprecipitates, analyzed at a constant voltage of 150 V for 40 min on 15% polyacrylamide gels, were transferred onto PVDF membranes (Bio-Rad) using a constant voltage of 100 V for 60 min. Nonspecific sites were blocked by incubating the blots overnight at 4ЊC in 10% (w/v) low-fat dried milk in 50 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20, pH 7.4 (TBST-I). Blots were washed twice with 10 mM Tris-HCl, 500 mM NaCl, 0.5% Tween-20, pH 7.4 (TBST-II), and incubated for 2 h at RT with specific antibodies diluted in TBST-I containing 0.1% NaN 3 at a concentration of 10 g/ml PC21 and 55 g/ml anti-G␣ i2 . The PVDF membrane was washed four times with TBST-II and incubated for 60 min at RT with horseradish peroxidase-conjugated goat anti-rabbit IgG diluted 1:5000 in TBST-I. The blot was washed twice with TBST-II and twice with TBST-I, then revealed by an ECL-Plus detection system (Amersham Pharmacia Bioteck, Rainham, U.K.). Molecular weight was determined by rainbow-colored protein molecular weight markers. Nonimmune rabbit IgGs at the same concentration were used as negative controls.
Changes in protein tyrosine phosphorylation were analyzed by using an anti-phosphotyrosine antibody. Aliquots of 2 ϫ 10 6 cells were extracted in 40 l of 1ϫ SDS-PAGE sample buffer [23] and heated in boiling water for 5 min. Boiled suspensions were loaded in SDS-PAGE gels at 10% acrylamide. After transferring onto PVDF membranes, following the above-described procedure, blots were incubated with mouse monoclonal anti-phosphotyrosine antibody (clone PT-66) diluted 1:2000 and revealed by the ECL-Plus detection system. The specificity of PT-66 was verified by preincubating with 20 mM ortho-phosphotyrosine (30 min at RT) that completely eliminated its reaction on immunoblots (data not shown). After scanning, images were analyzed using an ImageMaster software (Pharmacia Biotech, Uppsala, Sweden) to quantify the changes in intensity of various bands.
Statistical Analysis
Data were expressed as means Ϯ SEM. Statistical significance was determined by using the Student t-test and ANOVA. A P value Ͻ0.05 was considered significant. 
RESULTS
Effects of A 1 Agonist on Capacitation and AR
The effect of A 1 selective agonist was tested on uncapacitated human spermatozoa by substituting BSA with 10 nM, 100 nM, and 1 M CPA (K d 1 nM) [17] in the capacitative medium (BWW-BSA). Results are shown in Figure 1 . Capacitation was measured as the ability of sperm to undergo the AR when LPC, the inducer of AR, is added to the suspension. Pooled sperm samples used in the present study were characterized by 19 Ϯ 4% of spontaneous AR after 5 h incubation in BWW-BSA at 37ЊC in 5% CO 2 and by 56 Ϯ 6% induced AR after 15 min treatment with 100 g/ml LPC.
The substitution of BSA with CPA in the capacitative medium affected the capacitative status of human spermatozoa. The percentage of LPC-reacted cells was significantly different from the control (Fig. 1A) . However, the incubation of human spermatozoa in the presence of different concentrations of CPA did not affect the rate of spontaneous AR. Results clearly show that for each concentration tested the percentage of cells that underwent the spontaneous AR was not significantly modified (Fig. 1B) .
The effects of CPA on capacitated human spermatozoa are shown in Figure 2 . CPA, when used at 10 nM and 100 nM, was capable of inducing a moderate AR, whereas, when used at 1 M, CPA induced an AR rate that did not significantly differ from the control.
Specific A 1 antagonist, N 6 -cyclopentyl-9-methyladenine (N0840, K i 10 nM) [24] , at 100 nM concentration, did not exert any effect on either uncapacitated or capacitated spermatozoa (data not shown).
Effect of A 1 Agonist on Protein Tyrosine Phosphorylation
The appearance of tyrosine phosphorylation of human sperm proteins is correlated with capacitation. Changes in protein tyrosine phosphorylation of uncapacitated, BSA-capacitated, and CPA-capacitated human spermatozoa are reported in Figure 3 .
In the capacitated samples there was an increase in the tyrosine phosphorylation of a subset of proteins of M r ϭ 30 000-200 000. The most prominent tyrosine phosphorylated proteins had M r ϭ 95 000, M r ϭ 80 000, and M r ϭ 30 000. A protein of M r ϭ 62 000 was only present in BSAcapacitated sperm preparations.
Effect of A 1 Agonist on IP 3 Production
Human spermatozoa responded to the A 1 selective agonist CPA with a transient increase of IP 3 with a peak rise at 40 sec. The effects of A 1 AR agonist, antagonist, and phospholipase C (PLC) inhibitor on IP 3 production are shown in Table 1 .
CPA caused an increase in IP 3 approximately 100-fold over the basal. Specific A 1 antagonist N0840 did not cause IP 3 1H-pyrrole-2,5 dione (U73122) [25] , a permeable inhibitor of phosphatidyl inositol (PI)-PLC, there was no IP 3 accumulation, whereas the use of 2.5 M U73122 did not affect IP 3 accumulation.
The treatment of human spermatozoa with the same concentrations of U73122 for 15 min at 37ЊC did not affect spermatozoa viability significantly.
Coimmunoprecipitation Experiments
Results of immunoprecipitation studies are shown in Figure 4 . Using the PC21 antibody, G␣ i2 coprecipitated with A 1 ARs. Commercial antibody against G␣ i2 also coprecipitated a band of M r ϭ 40 000 corresponding to intact A 1 AR. Samples in which specific antibodies were substituted with nonimmune rabbit IgG were used as negative controls.
DISCUSSION
Ejaculated mammalian spermatozoa are not capable of fertilizing the oocyte until they acquire fertilizing potential by undergoing several physiological changes collectively called capacitation [1, 4] . This priming step is a prerequisite that allows the spermatozoa to bind to the zona pellucida and to undergo the exocytotic event occurring before fertilization, i.e., the AR. These events, triggered in vivo by residence for a finite period of time in the female reproductive tract, can be mimicked in vitro by incubating spermatozoa in a number of defined media. Several compounds have been described as modulators of both capacitation and AR [1] [2] [3] [4] [5] , but, although some progress has been made in understanding modulatory mechanisms, the molecules and the molecular bases of these mandatory events are still little known.
In this study we have shown a capacitative effect of the selective A 1 AR agonist added to uncapacitated human sperm suspensions. The number of capacitated spermatozoa, assessed by LPC-induced AR, was significantly increased when compared with BSA-capacitated spermatozoa. The capacitative effect showed no secondary inhibition at very high concentration of CPA compared to its K d value (1 nM). Spontaneous AR was not affected by the selective A 1 agonist. Capacitated human spermatozoa responded to the selective A 1 agonist, used at nanomolar concentrations, by marginally increasing the rate of the AR, but the result should be taken as of no biological significance. On the other hand, 1 M CPA reduced the rate of the AR to a value not significantly different from the control. This result agrees with a previous report [13] showing that 1 M CPA inhibited spontaneous acrosome loss in capacitated mouse sperm suspensions.
It has been reported that adenosine elicits a biphasic response in mouse and boar spermatozoa, first stimulating capacitation and then inhibiting the spontaneous AR [13, 14] . In our case, using agonist concentrations highly selective to A 1 AR, i.e., in the nanomolar range, we observed only stimulatory effects: CPA was a more efficient capacitative agent than BSA. The effects exerted by A 1 ARs are most probably common to mammalian species. We therefore suggest that the discrepancies between our data and those in the literature may be attributed to the different methodological and experimental procedures followed to assess capacitation and the AR. However, in the light of our results, and in agreement with Fraser, Funahashi, and colleagues [13, 14] , we propose that the stimulation of A 1 AR is not relevant to the AR. The fertilizing spermatozoa undergo the AR as a strictly controlled response to the oocyte-cumulus complex because spontaneously acrosome-reacted cells are nonfertilizing [26] .
Consistent with data in the literature [4, [27] [28] [29] [30] [31] [32] [33] , the capacitation induced by selective A 1 agonist was correlated with the increase of tyrosine phosphorylation of a protein of M r ϭ 95 000 that turns out to be the human homologue of the mouse proAKAP 82 [28, 32] . In agreement with Brewis et al. [33] , in BSA-and CPA-capacitated spermatozoa a capacitation-dependent increase of tyrosine phosphorylation of a protein of M r ϭ 80 000 was also found. It has been proposed that protein tyrosine phosphorylation and capacitation are regulated through a cAMP/protein kinase A pathway, a signal transduction cross talk probably universal to mammalian spermatozoa. G s protein subunits are absent in sperm cells [34] . Moreover, sperm adenylyl cyclase, the classical effector coupled to G s , is not regulated by G s [35] and is activated by increases of intracellular Ca 2ϩ concentration [36] [37] [38] .
The capacitative effect of A 1 selective agonist cannot be related to receptor-mediated cAMP increase as it is known that A 1 AR is coupled to G i /G o and therefore inhibits adenylyl cyclase activity [39] . However, these receptors can stimulate phosphatidyl inositol hydrolysis and release intracellular Ca 2ϩ stores by a pertussistoxin (PTX)-sensitive mechanism, suggesting that they also couple to the G ␤␥ /PLC␤ pathway through G i proteins [40] [41] [42] . In addition to directly activating PLC, the A 1 receptors are capable of potentiating the PLC response by a universal cross-talk mechanism between adenylyl cyclase inhibitory receptors and a range of G q -coupled receptors [43] . Whether by direct or indirect stimulation, A 1 receptors activate PLC and increase IP 3 levels. IP 3 , in turn, acting on specific IP 3 receptors, cooperates in controlling intracellular calcium release, thus eliciting cellular responses. IP 3 receptors are present in human spermatozoa [44] , and intracellular calcium concentrations are strongly related to the capacitative event [45, 46] .
We have previously demonstrated that the G-protein coupled to A 1 AR in mammalian spermatozoa is PTX sensitive [11] . In addition, we have shown by Ca 2ϩ -loading experiments [15] that the treatment of mammalian spermatozoa with selective A 1 agonist causes a Ca 2ϩ release similar to that caused by IP 3 . This finding suggested that A 1 receptors in spermatozoa signal via IP 3 .
In this study we provide evidence for A 1 -mediated IP 3 production through G␣ i2 protein. G proteins (G␣ i2 , G␣ i3 , G␣ q/11 ) have been identified and localized to discrete regions of human spermatozoa [34] . This subcellular distribution represents an important step to understanding the role of these signaling molecules in the regulation of sperm functions. Furthermore, the identification of receptors and effectors that couple to G proteins will provide additional clues to the role of G protein-coupled pathways in sperm physiology.
G␣ i proteins have a variable subcellular location in many cell lines [47, 48] . In human spermatozoa G␣ i2 is mainly localized in the acrosomal region [34] . The presence of this subunit together with G protein-coupled receptor kinase GRK4␥ [49] suggested their involvement in the signaling pathway to the AR [2] . It has been postulated that the stimulation of G␣ i2 causes sperm activation by releasing ␤␥ subunits that activate PLC [50, 51] . Here we produce evidence for the coupling of A 1 receptor with G␣ i2 subunit. It is plausible to suggest that ␤␥ subunits will activate PLC. The ␤ark1 minigene, a cellular scavenger G ␤␥ subunit, has been used effectively to identify the involvement of G ␤␥ subunit in modulating intracellular signal responses [40, 52, 53] .
Transfection techniques of spermatozoa are still in a preliminary stage [54] therefore our investigations on IP 3 accumulation have been limited to the use of putative PLC inhibitor U73122. The initial aim of this study was to block selectively the G i -mediated interaction of A 1 receptors with PLC. It has been reported [42] that rather than being a selective antagonist of PLC activity, U73122 can produce a number of undesired effects. In pancreatic acinar cells and NG105-15 cells, U73122 produces oscillations in intracellular calcium levels, activates cation channels, activates tyrosine kinases, and inhibits voltage-sensitive Ca 2ϩ channels and Ca 2ϩ entry into cells. Therefore the use of U73122 as a tool in establishing the dependence of stimulated cellular events on PLC activity is greatly limited. After checking the effects of each concentration of aminosteroid on human sperm viability, we observed that high concentrations of U73122 were effective in blocking IP 3 accumulation, whereas low concentrations of U73122, reported in the literature [25, [55] [56] [57] , did not interfere with IP 3 production.
In conclusion we have shown that the stimulation of A 1 AR with selective agonist leads to the capacitation of human spermatozoa without increasing the spontaneous AR rate. Capacitation is related to an increase of tyrosine phosphorylation of two proteins of M r ϭ 95 000 and 80 000 always found in capacitated spermatozoa.
A 1 ARs are coupled to PTX-sensitive G␣ i2 subunits and signal through IP 3 production, which follows the activation of PLC.
Several questions of considerable importance are still to be addressed. First, how can a receptor inhibiting adenylyl cyclase activate the cAMP/PKA pathway and how does the stimulation of this pathway lead to cross talk and upregulation of protein tyrosine phosphorylation? Second, is PLC directly activated by ␤␥ subunits or does a cross-talk mechanism between A 1 AR and G q -coupled receptors exist in sperm? The signaling processes underlying capacitation will be of help in elucidating the molecular basis of this extratesticular maturational event.
